Related Experiment Video
Updated: Mar 14, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure
Isabelle Johansson1, Ulf Dahlström2, Magnus Edner1
1Cardiology Unit, Department of Medicine K2, Karolinska Institutet, Stockholm, Sweden.
Insights
Type 2 diabetes mellitus (T2DM) significantly increases mortality risk in heart failure (HF) patients, especially with ischemic heart disease (IHD). Revascularization improves outcomes for T2DM patients with IHD, but does not eliminate the increased mortality risk.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Heart failure (HF) is a significant complication in type 2 diabetes mellitus (T2DM).
- The prognosis of ischemic HF and the impact of revascularization in T2DM patients require further investigation in real-world settings.
Purpose of the Study:
- To examine the impact of ischemic versus non-ischemic HF and prior revascularization on long-term prognosis.
- To compare outcomes in an unselected population of HF patients with and without T2DM.
Main Methods:
- Analysis of 35,163 patients from the Swedish Heart Failure Registry (SwedeHF) (2003-2011).
- Stratification by diabetes status, HF type (ischemic/non-ischemic), and revascularization history.
- Propensity score analysis to evaluate the effect of revascularization.
Main Results:
- T2DM predicted mortality irrespective of ischemic heart disease (IHD) presence.
- Patients with both T2DM and IHD had the highest mortality, attenuated by prior revascularization (HR: 0.82).
- Revascularization did not eliminate the increased mortality risk associated with T2DM.
Conclusions:
- Ninety percent of HF patients with T2DM have preventable comorbidities.
- IHD negatively impacts mortality in T2DM patients, with revascularization offering a beneficial effect.
- While revascularization improves outcomes, T2DM remains an independent predictor of mortality in HF.
Background:
Heart failure (HF) is a common and serious complication in type 2 diabetes mellitus (T2DM). The prognosis of ischemic HF and impact of revascularization in such patients have not been investigated fully in a patient population representing everyday practice.
Objectives:
This study examined the impact of ischemic versus nonischemic HF and previous revascularization on long-term prognosis in an unselected population of patients with and without T2DM.
Methods:
Patients stratified by diabetes status and ischemic or nonischemic HF and history of revascularization in the Swedish Heart Failure Registry (SwedeHF) from 2003 to 2011 were followed up for mortality predictors and longevity. A propensity score analysis was applied to evaluate the impact of previous revascularization.
Results:
Among 35,163 HF patients, those with T2DM were younger, and 90% had 1 or more associated comorbidities. Ischemic heart disease (IHD) occurred in 62% of patients with T2DM and 47% of those without T2DM, of whom 53% and 48%, respectively, had previously undergone revascularization. T2DM predicted mortality regardless of the presence of IHD, with adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of 1.40 (1.33 to 1.46) and 1.30 (1.22 to 1.39) in those with and without IHD, respectively. Patients with both T2DM and IHD had the highest mortality, which was further accentuated by the absence of previous revascularization (adjusted HR: 0.82 in favor of such treatment; 95% CI: 0.75 to 0.91). Propensity score adjustment did not change these results (HR: 0.87; 95% CI: 0.78 to 0.96). Revascularization did not abolish the impact of T2DM, which predicted mortality in those with (HR: 1.36; 95% CI: 1.24 to 1.48) and without (HR: 1.45; 95% CI: 1.33 to 1.56) a history of revascularization.
Conclusions:
Ninety percent of HF patients with T2DM have preventable comorbidities. IHD in patients with T2DM had an especially negative influence on mortality, an impact that was beneficially influenced by previous revascularization.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Pathophysiology of Heart Failure
Heart Failure V: Medical Management